Skip to main navigation Skip to search Skip to main content

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

  • Australian Ovarian Cancer Study (AOCS)

Research output: Contribution to journal › Article › peer-review

272   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology